CNJ-016

This brand name is authorized in United States.

Active ingredients

The drug CNJ-016 contains one active pharmaceutical ingredient (API):

1
UNII 7UB4J759TD - HUMAN VACCINIA VIRUS IMMUNE GLOBULIN
 

Vaccinia immunoglobulin provides passive immunity for individuals with complications to vaccinia virus vaccination. The exact mechanism of action is not known.
 
Read more about Vaccinia immunoglobulin

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 CNJ-016 Solution for injection MPI, US: SPL/PLR FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
US FDA, National Drug Code 60492-0173

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈